These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11267379)

  • 1. Transdermal estrogen therapy improves lipid profile and osteoporosis in postmenopausal liver transplant patients.
    Isoniemi H; Appelberg J; Nilsson C; Mäkelä P; Risteli J; Höckerstedt K
    Transplant Proc; 2001; 33(1-2):1472-3. PubMed ID: 11267379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of estrogen on bone-turnover and its prevention and control of osteoporosis ].
    Lin SQ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):728-9. PubMed ID: 15949374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 4. The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis.
    Bertonazzi A; Nelson B; Salvador J; Umland E
    Womens Health (Lond); 2015 Nov; 11(6):815-24. PubMed ID: 26618621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bone turnover and bone mass during tapering estrogen therapy: a preliminary report.
    Cantatore FP; Cicinelli E; Galantino P; Pepe V; Popolizio A; Savino F; Balzano G; Epifani S
    Arthritis Rheum; 1995 Feb; 38(2):292-4. PubMed ID: 7848323
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal therapy with estradiol and testosterone implants: bone protection?
    Britto R; Araújo L; Barbosa I; Silva L; Rocha S; Valente AP
    Gynecol Endocrinol; 2011 Feb; 27(2):96-100. PubMed ID: 20504104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.
    van den Brink HR; Lems WF; van Everdingen AA; Bijlsma JW
    Ann Rheum Dis; 1993 Apr; 52(4):302-5. PubMed ID: 8484698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate)].
    Gass R; Neff M
    Schweiz Med Wochenschr; 1995 Aug; 125(34):1583-91. PubMed ID: 7569830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in the prevention and treatment of osteoporosis.
    Delmas PD
    Osteoporos Int; 1997; 7 Suppl 1():S3-7. PubMed ID: 9205638
    [No Abstract]   [Full Text] [Related]  

  • 11. Lower doses of HRT protect bones.
    Health News; 2002 Jul; 8(7):7. PubMed ID: 12132506
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen therapy for osteoporosis: is it effective?
    Barzel US
    Hosp Pract (Off Ed); 1990 Jul; 25(7):95-9, 102, 105-8. PubMed ID: 2115537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of changes in biochemical markers of bone remodeling after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate. Gynécol Obstét Fertil 2003; 31 : 434-441].
    Ribot C
    Gynecol Obstet Fertil; 2003 Dec; 31(12):1079-80. PubMed ID: 14680796
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
    Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
    Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis.
    Genant HK
    Menopause Int; 2011 Jun; 17(2):44-9. PubMed ID: 21693498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
    Foster RH; Balfour JA
    Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipriflavone for the treatment of osteoporosis.
    Choi YK; Han IK; Yoon HK
    Osteoporos Int; 1997; 7 Suppl 3():S174-8. PubMed ID: 9536327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.